Advertisement
UK markets close in 6 hours 47 minutes

  • FTSE 100

    7,886.74
    +38.75 (+0.49%)
     

  • FTSE 250

    19,424.10
    +83.96 (+0.43%)
     

  • AIM

    744.26
    +1.14 (+0.15%)
     

  • GBP/EUR

    1.1680
    +0.0013 (+0.11%)
     

  • GBP/USD

    1.2472
    +0.0016 (+0.13%)
     

  • Bitcoin GBP

    49,282.68
    -1,624.22 (-3.19%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CRUDE OIL

    82.31
    -0.38 (-0.46%)
     

  • GOLD FUTURES

    2,394.40
    +6.00 (+0.25%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • DAX

    17,783.09
    +13.07 (+0.07%)
     

  • CAC 40

    8,019.37
    +37.86 (+0.47%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Shire to roadshow benchmark US dollar bond Sept 12-15: Source

Reuters - UK Focus

(Adds loan details)

By Hillary Flynn

NEW YORK, Sept 7 (IFR) - Drugmaker Shire Plc will start marketing a benchmark US dollar bond early next week, according to a note sent to investors seen by IFR.

Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) and Morgan Stanley (Xetra: 885836 - news) are arranging the fixed-income investor meetings, which will be held in the US and London between September 12-15, according to the note.

Bank of America (Swiss: BAC-USD.SW - news) is acting as logistics coordinator on the roadshow.

Shire (Xetra: S7E.DE - news) announced earlier this year that it had agreed to buy Baxalta International Inc in a US$32bn cash and stock offer.

In January, the company signed an US$18bn fully underwritten bank facility to finance the acquisition. (Reporting by Hillary Flynn; Editing by Paul Kilby and Shankar Ramakrishnan)